Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
07/05/2025
Delta Air Lines will suspend flights between New York's John F. Kennedy International Airport and Tel Aviv before May 19th.
Latest
3 m ago
Spot gold just fell below the $3370.00 per ounce level, currently trading at $3369.88 per ounce, down 1.76% on the day; COMEX gold futures are currently trading at $3377.70 per ounce, down 1.32% on the day.
4 m ago
Top officials from three ministries introduce a package of financial policies. What are the focus and hot issues that journalists are concerned about?
6 m ago
Barrick Gold Corporation announced on May 6th, local time, that after obtaining approval from shareholders, the company has officially changed its name to "Barrick Mining Corporation." In conjunction with the name change, the company's common stock ticker symbol on the New York Stock Exchange will be changed to "B" and will take effect on May 9th.
6 m ago
As it expands its copper business, gold giant Barrick is renamed Barrick Mining.
6 m ago
Every AI Express News, on May 6th, Open Source Securities released a research report giving a buy rating to Renfu Medicine (600079.SH). The main reasons for the rating include: 1) the performance of each subsidiary is stable, with strong core competitiveness in anesthesia products; 2) restructuring and return to core business are steadily progressing, and the leading position in anesthesia is expected to usher in valuation repair. (Daily Economic News)
See all latest